Skip to main page content

Vivian Yin MD, MPH

Amgen Co-Developed Symposium Co-Chair
Participates in 4 items

Dr. Vivian T. Yin is a clinical associate professor at the University of British Columbia specialized in ophthalmic plastic and reconstructive surgery. She worked at Memorial Sloan Kettering Cancer Center in New York and returned to Vancouver in 2019. After completing her medical degree and ophthalmology residency at the University of Toronto, she pursued a prestigious 2-year fellowship training in Ophthalmic Plastics and Reconstructive Surgery at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. She focuses on the treatment of periocular and orbital disease, with the use of genetic-based targeted therapy as her research interest, and speaks internationally on these topics. She is also a clinical trial investigator for multiple therapeutics in development for the treatment of thyroid eye disease.  

 

Financial disclosure: Dr. Yin has/had an affiliation (financial or otherwise) with a commercial organization:

  • Sling Therapeutics - Co-PI
  • Amgen - Consultant and Co-PI
  • AbCellar, Kriya - Consultant
  • Viridian - Clinical Trial PI
     

 

 

 

Sessions in which Vivian Yin MD, MPH participates

Thursday 24 June, 2021

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
6:00 PM
6:00 PM - 6:10 PM | 10 minutes
Award Winner

Access the Live Meeting: https://www.yourconference.live/COS

Friday 25 June, 2021

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
6:00 PM
6:01 PM - 6:24 PM | 23 minutes
Oculoplastics

Question 1: What area of oculoplastic surgery is most in need of innovation? Question 2: What has been the most impactful development/paper in Oculoplastics in the past few years? Question 3: What lasting impact will COVID-19 have on your practice? Question 4: What strategies do you use to continue to develop and stay on top of your game?

Sunday 27 June, 2021

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
11:00 AM
11:00 AM - 12:30 PM | 1 hour 30 minutes
Current Concepts

Learning ObjectivesAt the end of this session, participants will be able to: List key issues in managing patients with glaucoma and corneal transplantsDescribe the “Value Proposition” of glaucoma management from the Patient’s PerspectiveReview vision screening options for stroke admissions through the pathway from emergency department to dischargeDescribe the ocular manifestation of Zika and Ebola infe...

3:15 PM
3:15 PM - 4:45 PM | 1 hour 30 minutes
Skills Transfer Course (STC)Public Health and Global Ophthalmology